Andrew ElBardissi, M.D., is a Partner on the Medical Devices team at Deerfield and joined the Firm in 2017. Prior to Deerfield, Dr. ElBardissi was a Principal at Longitude Capital, where he focused on investments in medtech and biotechnology. Before that, he was an Associate in JPMorgan’s healthcare investment banking practice. Dr. ElBardissi received residency training in General Surgery at Harvard Medical School’s Brigham and Women’s Hospital and in Cardiothoracic Surgery at Stanford University. He has been independently funded by the National Institutes of Health and the Agency for Healthcare Research and Quality, has authored over 30 publications in leading peer-reviewed scientific journals and has presented his research at numerous medical and surgical conferences. Dr. ElBardissi holds an M.D. from the Mayo Clinic, an M.P.H. in Quantitative Methods from Harvard University, an M.B.A. from Harvard Business School and a B.S. with honors in Biology (Phi Beta Kappa) from the Schreyer Honors College at the Pennsylvania State University.

Abraham Kometz, M.D.
Abraham Kometz, M.D., is a Partner on the Medical Devices group at Deerfield and joined the Firm in 2014. Prior to Deerfield, Dr. Kometz was a Partner at Ascent Biomedical Ventures, where he led investment efforts in biotechnology, pharmaceuticals, medical devices and healthcare information technology. Before Ascent, Dr. Kometz served as the head of corporate development at a specialty pharmaceutical company focused on pediatrics. He was also a member of the Healthcare Practice at McKinsey & Company in New York, where he worked on matters including strategy, valuation, organizational change and cost-reduction. Dr. Kometz received his medical doctorate from the University of the Witwatersrand Medical School, South Africa. He began his career as a clinician in South Africa and went on to found and build a group of clinics.